Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USA.
Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USA.
J Colloid Interface Sci. 2017 Dec 1;507:119-130. doi: 10.1016/j.jcis.2017.07.090. Epub 2017 Jul 26.
Exploitation of lipid nanoparticles for oral delivery of nutrients and drugs is limited by their poor stability under gastrointestinal tract and low loading capacity, unless a high concentration of synthetic surfactants is formulated. The main objective of present study is to design a series of new formulations for solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) that are suitable for potential oral delivery applications, using natural biopolymers, i.e. sodium caseinate (NaCas) as emulsifier and pectin as coating, with minimal addition of a synthetic surfactant, Tween 80. Effects of pectin coating, concentration of Tween 80, thermal treatment (80°C for 30min), as well as two chemical cross-linkers on the particulate characteristics, stability, encapsulation efficiency, controlled release and drying feasibility were comprehensively investigated. The intermolecular interactions and cross-linking reactions were studied using Fourier transform infrared spectroscopy. Tween 80 at 0.15% (w/v) together with 0.15% (w/v) NaCas was proved effective to obtain stable cross-linked pectin-coated SLN (PSLN) under 200nm with high loading capacity for curcumin, while NLC prepared under the same condition failed to pass storage stability test. The 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide/N-hydroxysuccinimide (EDC/NHS) cross-linked PSLN exhibited superior characteristics than glutaradehyde (GA) cross-linked PSLN, especially for the stability and controlled release under simulated gastrointestinal conditions, with curcumin studied as a model compound. The feasibility of both nano spray drying and freeze-drying technologies were both investigated to transform of colloidal lipid nanoparticles into dry powders. Our results demonstrated a novel strategy to prepare small and homogenous SLN with exceptional GI stability and high loading capacity as a potential oral delivery system.
利用脂质纳米粒进行营养物质和药物的口服递送受到限制,因为它们在胃肠道中稳定性差,载药量低,除非配方中含有高浓度的合成表面活性剂。本研究的主要目的是设计一系列适用于潜在口服应用的新型固体脂质纳米粒(SLN)和纳米结构脂质载体(NLC)制剂,使用天然生物聚合物,即酪蛋白酸钠(NaCas)作为乳化剂,果胶作为包衣,仅需添加少量合成表面活性剂吐温 80。本文综合研究了果胶包衣、吐温 80 浓度、热处理(80°C 30min)以及两种化学交联剂对颗粒特性、稳定性、包封效率、控制释放和干燥可行性的影响。使用傅里叶变换红外光谱研究了分子间相互作用和交联反应。结果表明,0.15%(w/v)吐温 80 与 0.15%(w/v)NaCas 联合使用,可有效获得具有高载药量的稳定交联果胶包覆 SLN(PSLN),粒径在 200nm 左右,而在相同条件下制备的 NLC 未能通过储存稳定性测试。1-乙基-3-(3-二甲基氨基丙基)碳化二亚胺/N-羟基琥珀酰亚胺(EDC/NHS)交联 PSLN 比戊二醛(GA)交联 PSLN 具有更好的特性,特别是在模拟胃肠道条件下的稳定性和控制释放方面,以姜黄素为模型化合物进行了研究。还研究了纳米喷雾干燥和冷冻干燥技术将胶体脂质纳米粒转化为干粉的可行性。我们的研究结果证明了一种制备具有 GI 稳定性好、载药量高的小而均匀的 SLN 的新策略,可作为一种潜在的口服递送系统。